Investor Ideas #Potcasts #Cannabis News
and #Stocks on the Move: CSE: $HUGE.C,
TSXV: $HIP.V, TSXV: $N.V, CSE: $NSHS.C, CSE: $MTEC.C, TSXV: $GENE.V
and #Stocks on the Move: CSE: $HUGE.C,
TSXV: $HIP.V, TSXV: $N.V, CSE: $NSHS.C, CSE: $MTEC.C, TSXV: $GENE.V
Delta, Kelowna, BC –September 11, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2018/cannabis/09111Potcasts-CSE-HUGE-TSXV-HIP-N-NSHS-MTEC-GENE.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast – looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today we will be looking at announcements from FSD
Pharma Inc. trading on the CSE as HUGE and the OTC as FSDDF, Newstrike Brands
Ltd. trading on the TSX-Venture as HIP, Namaste Technologies Inc. trading on the TSX-Venture as
N, NanoSphere Health Sciences, Inc. trading on the CSE
as NSHS and OTC as NSHSF, Cannvas MedTech Inc. trading on the CSE as MTEC and INVICTUS MD STRATEGIES CORP. trading on the
TSX-Venture as GENE.
Pharma Inc. trading on the CSE as HUGE and the OTC as FSDDF, Newstrike Brands
Ltd. trading on the TSX-Venture as HIP, Namaste Technologies Inc. trading on the TSX-Venture as
N, NanoSphere Health Sciences, Inc. trading on the CSE
as NSHS and OTC as NSHSF, Cannvas MedTech Inc. trading on the CSE as MTEC and INVICTUS MD STRATEGIES CORP. trading on the
TSX-Venture as GENE.
FSD Pharma Inc. announced that pursuant to
its Stock Option Plan, the Board approved the grant of 3,000,000 stock options
for class B subordinate voting shares of the Company on August 14, 2018 to Dr.
Raza Bokhari following his appointment as a Director. The Options vest
immediately and are exercisable at a price of $0.13 for a period of five years.
The Company has also cancelled 15,000,000 stock options that had been
previously issued at $0.05.
its Stock Option Plan, the Board approved the grant of 3,000,000 stock options
for class B subordinate voting shares of the Company on August 14, 2018 to Dr.
Raza Bokhari following his appointment as a Director. The Options vest
immediately and are exercisable at a price of $0.13 for a period of five years.
The Company has also cancelled 15,000,000 stock options that had been
previously issued at $0.05.
The Board has also approved an additional
grant of 40,000,000 Options to Dr. Bokhari exercisable at a price of $0.74 for
a period of five years. The Options shall only vest and become exercisable upon
the completion of the following conditions:
grant of 40,000,000 Options to Dr. Bokhari exercisable at a price of $0.74 for
a period of five years. The Options shall only vest and become exercisable upon
the completion of the following conditions:
The Company becomes listed on the NASDAQ
stock exchange, or merges with a NASDAQ-listed company to the satisfaction of
the Board; and
stock exchange, or merges with a NASDAQ-listed company to the satisfaction of
the Board; and
Adequate financing is arranged for the
listing of the Company on the NASDAQ stock exchange or merger of the Company
with a NASDAQ-listed company referenced above, to the satisfaction of the
Board.
listing of the Company on the NASDAQ stock exchange or merger of the Company
with a NASDAQ-listed company referenced above, to the satisfaction of the
Board.
Newstrike Brands Ltd. announced that it has
been approved for graduation from Tier 2 to Tier 1 issuer status on the TSX
Venture Exchange.
been approved for graduation from Tier 2 to Tier 1 issuer status on the TSX
Venture Exchange.
"Advancing to a Tier 1 listing on the
TSXV reflects Newstrike's continued progress and development as a company with
Canada's legalized adult-use cannabis market fast approaching," said Jay
Wilgar, Chief Executive Officer and Chairman of Newstrike. "We're excited
to reach this listing milestone and we look forward to others as we execute our
strategy to build Up Cannabis as a premier adult-use cannabis brand across
Canada."
TSXV reflects Newstrike's continued progress and development as a company with
Canada's legalized adult-use cannabis market fast approaching," said Jay
Wilgar, Chief Executive Officer and Chairman of Newstrike. "We're excited
to reach this listing milestone and we look forward to others as we execute our
strategy to build Up Cannabis as a premier adult-use cannabis brand across
Canada."
The TSXV classifies issuers into different
tiers based on standards including historical financial performance, stage of
development and financial resources. Tier 1 is the TSXV's premier tier and is
reserved for the TSXV's most advanced issuers.
tiers based on standards including historical financial performance, stage of
development and financial resources. Tier 1 is the TSXV's premier tier and is
reserved for the TSXV's most advanced issuers.
Newstrike is the parent company of Up
Cannabis, a licensed producer of cannabis that is licensed to both cultivate
and sell cannabis in all acceptable forms. Newstrike, through Up Cannabis and
together with select strategic partners, including Canada's iconic musicians
The Tragically Hip, is developing a diverse network of high quality cannabis
brands.
Cannabis, a licensed producer of cannabis that is licensed to both cultivate
and sell cannabis in all acceptable forms. Newstrike, through Up Cannabis and
together with select strategic partners, including Canada's iconic musicians
The Tragically Hip, is developing a diverse network of high quality cannabis
brands.
Namaste Technologies Inc. announced that
further to its July 23rd news release, the Company intends to continue to pursue
the listing of its common shares on the NASDAQ Capital Market
("NASDAQ"). Due to Company developments and a recent increase in its
share price, the Company is now closer to meeting the requirements to list on
NASDAQ. Based on the Company's current share price, and the anticipated
increase in sales through the launch of its ACMPR sales license, the Company
currently intends on reaching the share-price target organically without any
share consolidation.
further to its July 23rd news release, the Company intends to continue to pursue
the listing of its common shares on the NASDAQ Capital Market
("NASDAQ"). Due to Company developments and a recent increase in its
share price, the Company is now closer to meeting the requirements to list on
NASDAQ. Based on the Company's current share price, and the anticipated
increase in sales through the launch of its ACMPR sales license, the Company
currently intends on reaching the share-price target organically without any
share consolidation.
By up-listing to the NASDAQ, the Company
believes it will gain new exposure and access to a larger base of retail and
institutional investors in the US and internationally. The NASDAQ is well-known
as a technology exchange and with Namaste being a leading technology company in
the cannabis space, management feels strongly that the up-listing would bring
significant value to the Company.
believes it will gain new exposure and access to a larger base of retail and
institutional investors in the US and internationally. The NASDAQ is well-known
as a technology exchange and with Namaste being a leading technology company in
the cannabis space, management feels strongly that the up-listing would bring
significant value to the Company.
NanoSphere Health Sciences, Inc., the
biotechnology leader behind the patented NanoSphere Delivery System™, has
entered into a revenue-sharing agreement to expand its Evolve Formulas product
line to Indiana with Jeff DeHart, Managing Member of Evolve Formulas of
Indiana, LLC. Under the agreement, NanoSphere will introduce a new,
hemp-derived offering to the Indiana market. The NanoSerum™ Hemp products will
be available for purchase in mid-September.
biotechnology leader behind the patented NanoSphere Delivery System™, has
entered into a revenue-sharing agreement to expand its Evolve Formulas product
line to Indiana with Jeff DeHart, Managing Member of Evolve Formulas of
Indiana, LLC. Under the agreement, NanoSphere will introduce a new,
hemp-derived offering to the Indiana market. The NanoSerum™ Hemp products will
be available for purchase in mid-September.
NanoSerum™ Hemp, like the other Evolve
Formulas products, will leverage NanoSphere Health Sciences' next-generation
NanoSphere Delivery System™ to provide fast-acting relief from pain and
inflammation. Similar to marijuana, hemp is derived from the cannabis plant and
carries a vast range of medical benefits; however, it is genetically distinct
and does not contain THC. The hemp-derived NanoSerum™ will be available in 5ML
and 10ML sizes. There are already 1,500 pre-orders to-date.
Formulas products, will leverage NanoSphere Health Sciences' next-generation
NanoSphere Delivery System™ to provide fast-acting relief from pain and
inflammation. Similar to marijuana, hemp is derived from the cannabis plant and
carries a vast range of medical benefits; however, it is genetically distinct
and does not contain THC. The hemp-derived NanoSerum™ will be available in 5ML
and 10ML sizes. There are already 1,500 pre-orders to-date.
"With a proven track record of success
already under our belt in Colorado—we are eager to continue Evolve Formulas'
expansion by forging a path into the Midwest with an exciting new product,
which delivers the benefits of hemp precisely and effectively," said
Robert Sutton, CEO and Chairman of NanoSphere Heath Sciences and Evolve
Formulas. "Bringing our unique delivery system to the residents of Indiana
will serve to not only educate the public on the extraordinary medical
potential of hemp, but also set the bar for a high standard of hemp-derived
products in this untapped market."
already under our belt in Colorado—we are eager to continue Evolve Formulas'
expansion by forging a path into the Midwest with an exciting new product,
which delivers the benefits of hemp precisely and effectively," said
Robert Sutton, CEO and Chairman of NanoSphere Heath Sciences and Evolve
Formulas. "Bringing our unique delivery system to the residents of Indiana
will serve to not only educate the public on the extraordinary medical
potential of hemp, but also set the bar for a high standard of hemp-derived
products in this untapped market."
NanoSphere Health Sciences utilizes a method
of nano-encapsulating cannabis molecules in lipid membranes so they can be
transported through layers of the skin and into the bloodstream in minutes.
This provides rapid results, precise dosages and high bioavailability of
cannabis which is ideal for localized pain and inflammation, as well as
providing systemic therapy and relief from anxiety. With plans to expand into
pharmaceutical, nutraceutical, cosmeceutical and animal health divisions in the
coming years, the new hemp serum is another example of how NanoSphere's
technology can be applied to various formats and industries.
of nano-encapsulating cannabis molecules in lipid membranes so they can be
transported through layers of the skin and into the bloodstream in minutes.
This provides rapid results, precise dosages and high bioavailability of
cannabis which is ideal for localized pain and inflammation, as well as
providing systemic therapy and relief from anxiety. With plans to expand into
pharmaceutical, nutraceutical, cosmeceutical and animal health divisions in the
coming years, the new hemp serum is another example of how NanoSphere's
technology can be applied to various formats and industries.
Cannvas MedTech Inc., a leading business
technology company in the cannabis space, and Blox Labs Inc. (CSE: BLOX), a
technology development company focused on creating best-in-class blockchain
software, are pleased to announce the signing of a letter of intent, to negotiate,
in good faith, a data analytics agreement with respect to "CannaBLOX", a Blockchain-based
smart contract supply chain management platform for the legalized Cannabis
industry that BLOX is developing in partnership with Liberty Leaf Holdings Ltd.
(CSE: LIB) (OTC: LIBFF).
technology company in the cannabis space, and Blox Labs Inc. (CSE: BLOX), a
technology development company focused on creating best-in-class blockchain
software, are pleased to announce the signing of a letter of intent, to negotiate,
in good faith, a data analytics agreement with respect to "CannaBLOX", a Blockchain-based
smart contract supply chain management platform for the legalized Cannabis
industry that BLOX is developing in partnership with Liberty Leaf Holdings Ltd.
(CSE: LIB) (OTC: LIBFF).
Under the terms of the Agreement, the Parties
will assess, amongst other endeavors, various synergies that may exist through
the utilization of Cannvas Data's analytical modeling framework and the various
data capture opportunities that the CannaBLOX platform would provide. Cannvas will develop specific parameters
within its existing Cannvas Data framework to collect and analyze transactional
and industry data from the CannaBLOX platform, and their strategic industry
partners. CannaBLOX would in turn gain access to a broad industry-level dataset
as they rollout their preliminary module during a beta test phase.
will assess, amongst other endeavors, various synergies that may exist through
the utilization of Cannvas Data's analytical modeling framework and the various
data capture opportunities that the CannaBLOX platform would provide. Cannvas will develop specific parameters
within its existing Cannvas Data framework to collect and analyze transactional
and industry data from the CannaBLOX platform, and their strategic industry
partners. CannaBLOX would in turn gain access to a broad industry-level dataset
as they rollout their preliminary module during a beta test phase.
INVICTUS MD STRATEGIES CORP. announced that
its wholly-owned subsidiary, Acreage Pharms Ltd., has been granted conditional
approval to become a registered supplier with the Saskatchewan Liquor and
Gaming Authority ("SLGA") once legislation is implemented on October
17, 2018. In the interim, and subject to any federal restrictions, Acreage
Pharms is eligible to supply product to authorized provincial wholesalers and
retailers in advance of October 17.
its wholly-owned subsidiary, Acreage Pharms Ltd., has been granted conditional
approval to become a registered supplier with the Saskatchewan Liquor and
Gaming Authority ("SLGA") once legislation is implemented on October
17, 2018. In the interim, and subject to any federal restrictions, Acreage
Pharms is eligible to supply product to authorized provincial wholesalers and
retailers in advance of October 17.
"We are thrilled to become a registered
supplier in Saskatchewan, our third provincial agreement behind British
Columbia and Alberta," said Dan Kriznic CEO and Chairman for Invictus.
"We can feel the momentum building ahead of legalization on October 17,
2018 and are actively seeking agreements with additional provinces to help
ensure governments across Canada have enough supply to meet consumer
demand."
supplier in Saskatchewan, our third provincial agreement behind British
Columbia and Alberta," said Dan Kriznic CEO and Chairman for Invictus.
"We can feel the momentum building ahead of legalization on October 17,
2018 and are actively seeking agreements with additional provinces to help
ensure governments across Canada have enough supply to meet consumer
demand."
Invictus is set to gain access to the retail
market in Saskatchewan through an LOI with GTEC Holdings Ltd. (TSXV: GTEC) that
provides the Company with an opportunity to fill purchase orders that GTEC is
seeking from third party licensed producers for the purposes of supporting GTECs
distribution channels.
market in Saskatchewan through an LOI with GTEC Holdings Ltd. (TSXV: GTEC) that
provides the Company with an opportunity to fill purchase orders that GTEC is
seeking from third party licensed producers for the purposes of supporting GTECs
distribution channels.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
all listeners to read our disclaimers and disclosures on the Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Potcasts is now a certified word mark Trademark on the blockchain through
Cognate, Inc. CM Certification
Cognate, Inc. CM Certification
Investorideas.com podcasts are also available on iTunes, Spotify,
Google Play Music, Stitcher, iHeartradio, Spreaker and Tunein.
Google Play Music, Stitcher, iHeartradio, Spreaker and Tunein.
If you would like to be a guest or sponsor this podcast contact
Investorideas.com
Investorideas.com
Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via Spreaker,
iHeartradio and Tunein.
iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via Spreaker,
iHeartradio and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Investing Ideas
Big Investing Ideas
Investorideas.com is a recognized news source
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and
stock news column, Investor
Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the Stock Guru daily podcast on Support and Resistance Trading.
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and
stock news column, Investor
Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the Stock Guru daily podcast on Support and Resistance Trading.
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Contact each company directly regarding content and
press release questions. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: shttps://www.investorideas.com/About/Disclaimer.asp.
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Contact each company directly regarding content and
press release questions. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: shttps://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Do you trade or invest in Marijuana / Hemp
Stocks? Check out our stock directory of
publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana / Hemp Stocks
Stocks? Check out our stock directory of
publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana / Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing
No comments:
Post a Comment